Page last updated: 2024-08-21

hydantoins and Retinal Neovascularization

hydantoins has been researched along with Retinal Neovascularization in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afzal, A; Caballero, S; Edelhauser, H; Geroski, D; Grant, MB; Hochhaus, G; Jurczyk, S; Miller, RC; Palii, SS; Pan, H; Reubi, JC; Shapiro, G; Shaw, LC; Tan, Y1

Other Studies

1 other study(ies) available for hydantoins and Retinal Neovascularization

ArticleYear
Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Autoradiography; Cell Movement; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Gene Expression; Humans; Imidazolidines; Injections; Mice; Mice, Inbred C57BL; Octreotide; Ophthalmic Solutions; Polymerase Chain Reaction; Rabbits; Receptors, Somatostatin; Retinal Neovascularization; RNA; Sclera; Treatment Outcome; Vitreous Body

2008